Gaudium IVF and Women Health Ltd

Gaudium IVF and Women Health Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Gaudium IVF and Women Health Ltd, a micro-cap player in the Healthcare Services sector, has seen a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects a recalibration in price attractiveness amid evolving market dynamics and peer comparisons, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios signalling a less compelling investment case despite solid operational metrics.

Gaudium IVF and Women Health Ltd has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 15 August 2026, reflecting deteriorating financial performance, weakening technical indicators, and an expensive valuation despite some revenue growth. The micro-cap healthcare services company faces significant challenges that have prompted a reassessment of its investment appeal.

Gaudium IVF and Women Health Ltd, a micro-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Recent technical indicators, including MACD, RSI, and moving averages, signal a cautious outlook for investors amid declining price performance and sector headwinds.

Gaudium IVF and Women Health Ltd, a micro-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish trend to a sideways pattern. Despite a modest day gain of 1.99%, the stock’s technical indicators present a complex picture, prompting a downgrade in its Mojo Grade from Hold to Sell as of 10 August 2026.

Gaudium IVF and Women Health Ltd, a micro-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend. This change comes amid a 1.98% decline in the stock price to ₹128.40 on 11 Aug 2026, reflecting growing investor caution despite some positive longer-term returns relative to the Sensex.

Gaudium IVF and Women Health Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 08 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Gaudium IVF and Women Health Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 July 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 26 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

At Rs 163.18, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Gaudium IVF and Women Health Ltd locked at its upper circuit of 5% on 21 Jul 2026, with buyers queuing and no sellers willing to part with shares.

With a decisive surge to Rs 163.7 on 22 Jul 2026, Gaudium IVF and Women Health Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over the past week.

Extending its winning streak to five consecutive sessions, Gaudium IVF and Women Health Ltd surged 4.52% on 22 Jul 2026 to touch a fresh all-time high of Rs 163.7, significantly outpacing the Sensex which declined 0.77% on the same day.

After a sustained rally over the past four days, Gaudium IVF and Women Health Ltd surged to a fresh 52-week and all-time high of Rs 155 on 21 Jul 2026, marking an 18.12% gain during this winning streak. This milestone comes amid a backdrop of broad technical momentum that has propelled the stock well above all key moving averages.

Extending its winning streak to four consecutive sessions, Gaudium IVF and Women Health Ltd surged to a fresh all-time high of Rs 155 on 21 Jul 2026, outperforming its sector and the broader market by a wide margin.

At Rs 136.60, sellers were still queuing — but there were no buyers willing to take the other side. Gaudium IVF and Women Health Ltd locked at its lower circuit of 5% on 20 Jul 2026, with unfilled sell orders and a frozen price.

Surging to an all-time high of Rs 146.65 on 20 Jul 2026, Gaudium IVF and Women Health Ltd has demonstrated remarkable price momentum, outpacing its sector and marking a significant milestone in its trading history.

Gaudium IVF and Women Health Ltd has reached a significant milestone by touching an all-time high price of Rs.144 on 20 July 2026, marking a notable achievement in the healthcare services sector. This peak reflects the company’s sustained performance and positive market momentum over recent months.